This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Other. Active years: 2011.
Company Filing History:
1 out of 834,411 Years Active: 2011
Title: Rumen Tsanev: Innovator in Autoimmune Disease Research
Introduction
Rumen Tsanev is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of autoimmune diseases, particularly through his innovative research on human interferon-gamma.
Latest Patents
Rumen Tsanev holds a patent for an "Inhibitor of endogenous human interferon-gamma." This invention is particularly relevant in the context of autoimmune diseases, especially multiple sclerosis. The patent describes inactivated protein derivatives of human interferon-gamma (hIFN-γ) that maintain their affinity to the hIFN-γ receptor. These derivatives are genetically modified variants of hIFN-γ, where the C-terminal part of the molecule is either deleted or replaced with a polypeptide sequence from another human protein. Additionally, the invention includes recombinant hIFN-γ that has been inactivated through physical or chemical methods.
Career Highlights
Throughout his career, Rumen Tsanev has worked with various companies, including Gunther and Rolf. His work has focused on advancing the understanding and treatment of autoimmune diseases, contributing to the scientific community's knowledge in this critical area.
Collaborations
Rumen Tsanev has collaborated with notable individuals in his field, including Rolf Gunther and Ivan Nikolov Ivanov. These collaborations have further enriched his research and innovations.
Conclusion
Rumen Tsanev's work in the field of autoimmune diseases, particularly through his patent on human interferon-gamma inhibitors, showcases his dedication to advancing medical science. His contributions are vital for the ongoing research and treatment of conditions like multiple sclerosis.